Catalyst Pharmaceuticals shareholders elect directors and approve incentive plan amendment

CATALYST PHARMACEUTICALS, INC.

All seven director nominees elected: Daly, McEnany, Denkhaus, Harper, O'Keeffe, Thompson, Tierney.
Amendment to 2018 Stock Incentive Plan approved with 86.8M for, 2.9M against, 168k abstained.
Advisory vote on 2023 executive compensation passed: 84.2M for, 5.5M against, 182k abstained.
Ratification of Grant Thornton as independent auditor approved: 99.6M for, 2.0M against, 79k abstained.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.